Are you Dr. Spitz?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 31 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd.
Houston, TX 77030Phone+1 713-792-6161
Summary
- Dr. Margaret Spitz, MD is a family physician in Houston, Texas. She is affiliated with University of Texas M.D. Anderson Cancer Center.
Publications & Presentations
PubMed
- 200 citationsProgress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward.Gary J. Kelloff, Scott M. Lippman, Andrew J. Dannenberg, Caroline C. Sigman, Homer L. Pearce
Clinical Cancer Research. 2006-06-15 - 396 citationsLarge-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypesJames D. McKay, Rayjean J. Hung, Younghun Han, Xuchen Zong, Robert Carreras-Torres
Nature Genetics. 2017-06-12 - 890 citationsCharacterizing the cancer genome in lung adenocarcinomaBarbara A. Weir, Michele S. Woo, Gad Getz, Sven Perner, Li Ding
Nature. 2007-12-06
Press Mentions
Baylor Awarded $17.5 Million in CPRIT Grants for Cancer ResearchMay 19th, 2021- Debate Swirls Around the Science of EpidemiologyNovember 17th, 1999
Grant Support
- Training Program In Pediatric Cancer Epidemiology And ControlNational Cancer Institute2011
- Inflammation Genes And Lung Cancer RiskNational Cancer Institute2011
- Inflammation Genes And Lung Cancer RiskNational Cancer Institute2008–2011
- Biobehavioral-Smoking Profiles In Mexican-American YouthNational Cancer Institute2004–2008
- Adenocarcinoma Of The Lung: Role Of NNK SusceptibilityNational Cancer Institute2004–2008
- Clinical And Epidemiologic Center For Biomarkers Of UppeNational Cancer Institute2001–2004
- Ecogenetics Of Lung CancerNational Cancer Institute1999–2003
- Genetic Susceptibility Markers In Surrogate/Target TissuNational Cancer Institute2002
- Core--Molecular Epidemiology And EcogeneticsNational Institute Of Environmental Health Sciences2001–2002
- Head/Neck Cancer Susceptibility Markers In Second Primary TumorsNational Cancer Institute1997–2002
- Core--Clinical And Molecular EpidemiologyNational Cancer Institute1996–2002
- Clinical And Epidemiologic Center For BiomarkersNational Cancer Institute2000
- Core--Environmental Epidemiology And EcogeneticsNational Institute Of Environmental Health Sciences1996–2000
- Risk Assessment Models For Lung CancerNational Cancer Institute1999
- Lung Cancer Susceptibility In Former SmokersNational Cancer Institute1996–1999
- Environmental &Genetic Determinants Of Prostate CancerNational Cancer Institute1995–1999
- Ecogenetic Study Of Lung Cancer In MinoritiesNational Cancer Institute1995–1998
- Ecogenetics Of Lung Cancer In Minority PopulationsNational Cancer Institute1991–1994
- Environmental And Genetic InteractionsNational Cancer Institute1989–1990
